Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000720198> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2000720198 endingPage "1417" @default.
- W2000720198 startingPage "1411" @default.
- W2000720198 abstract "Background. Neoral, a microemulsion formulation of cyclosporine, was approved for use in the United States in 1995. Many studies comparing Neoral and Sandimmune have been conducted, and although most state that Neoral is the superior cyclosporine formulation, results have failed to conclusively demonstrate this claim. The aim of this meta-analysis was to compare the safety and efficacy of Neoral and Sandimmune. Methods. Publications comparing the use of Neoral and Sandimmune were reviewed for demographic variables, adverse events, rejection incidence, graft losses, and serum creatinine. Neoral and Sandimmune were compared in all patients and in the following subgroups: (1) age (adult or pediatric), (2) transplant type (kidney, liver, or heart), (3) indication (de novo or stable), and (4) study design (randomized prospective trials versus nonrandomized, blinded versus openlabeled studies). Results. The rate of graft loss was similar when comparing Neoral and Sandimmune in all analyses. The incidence of rejection was lower in Neoral-treated de novo renal, liver, and cardiac transplants (P < 0.05). There were significantly more adverse events in Sandimmune-treated de novo liver transplants than Neoral-treated de novo liver transplants (P < 0.00001). When considering only randomized prospective trials, the incidence of rejection was lower in Neoral-treated de novo and stable patients (P < 0.05). However, there were more adverse events in Neoral-treated stable patients (P < 0.00001). When considering only blinded studies, there were more adverse events in Neoral-treated patients (P < 0.05), whereas in open-labeled studies there was no difference in adverse events comparing Neoral and Sandimmune (P = NS). Conclusions. Considering all published trials, the data seem to indicate that Neoral therapy is preferred because of a lower rejection incidence, with a trend toward less adverse events. However, when limiting the analysis to only randomized prospective trials, and specifically assessing blinded studies, the data become less clear. Neoral use was associated with more adverse events in blinded studies, and Sandimmune use was associated with more adverse events in open-labeled studies. Careful individual consideration must be given in choosing the best possible cyclosporine formulation." @default.
- W2000720198 created "2016-06-24" @default.
- W2000720198 creator A5015460152 @default.
- W2000720198 creator A5055961830 @default.
- W2000720198 creator A5072538988 @default.
- W2000720198 creator A5088697218 @default.
- W2000720198 date "1999-06-01" @default.
- W2000720198 modified "2023-09-30" @default.
- W2000720198 title "THE EVALUATION OF THE SAFETY AND TOLERABILITY OF TWO FORMULATIONS OF CYCLOSPORINE: NEORAL AND SANDIMMUNE" @default.
- W2000720198 cites W1965084608 @default.
- W2000720198 cites W1969837093 @default.
- W2000720198 cites W1973744227 @default.
- W2000720198 cites W2005677975 @default.
- W2000720198 cites W2007066337 @default.
- W2000720198 cites W2008638063 @default.
- W2000720198 cites W2028293443 @default.
- W2000720198 cites W2029531864 @default.
- W2000720198 cites W2036255046 @default.
- W2000720198 cites W2042809412 @default.
- W2000720198 cites W2055960142 @default.
- W2000720198 cites W2057567503 @default.
- W2000720198 cites W2073181045 @default.
- W2000720198 cites W2084942054 @default.
- W2000720198 cites W2089283709 @default.
- W2000720198 cites W2106911513 @default.
- W2000720198 doi "https://doi.org/10.1097/00007890-199906150-00004" @default.
- W2000720198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10385078" @default.
- W2000720198 hasPublicationYear "1999" @default.
- W2000720198 type Work @default.
- W2000720198 sameAs 2000720198 @default.
- W2000720198 citedByCount "53" @default.
- W2000720198 countsByYear W20007201982013 @default.
- W2000720198 countsByYear W20007201982014 @default.
- W2000720198 countsByYear W20007201982016 @default.
- W2000720198 countsByYear W20007201982017 @default.
- W2000720198 countsByYear W20007201982022 @default.
- W2000720198 countsByYear W20007201982023 @default.
- W2000720198 crossrefType "journal-article" @default.
- W2000720198 hasAuthorship W2000720198A5015460152 @default.
- W2000720198 hasAuthorship W2000720198A5055961830 @default.
- W2000720198 hasAuthorship W2000720198A5072538988 @default.
- W2000720198 hasAuthorship W2000720198A5088697218 @default.
- W2000720198 hasBestOaLocation W20007201981 @default.
- W2000720198 hasConcept C126322002 @default.
- W2000720198 hasConcept C126894567 @default.
- W2000720198 hasConcept C141071460 @default.
- W2000720198 hasConcept C197934379 @default.
- W2000720198 hasConcept C2778375690 @default.
- W2000720198 hasConcept C2779528694 @default.
- W2000720198 hasConcept C2779609443 @default.
- W2000720198 hasConcept C2780306776 @default.
- W2000720198 hasConcept C2911091166 @default.
- W2000720198 hasConcept C71924100 @default.
- W2000720198 hasConcept C90924648 @default.
- W2000720198 hasConceptScore W2000720198C126322002 @default.
- W2000720198 hasConceptScore W2000720198C126894567 @default.
- W2000720198 hasConceptScore W2000720198C141071460 @default.
- W2000720198 hasConceptScore W2000720198C197934379 @default.
- W2000720198 hasConceptScore W2000720198C2778375690 @default.
- W2000720198 hasConceptScore W2000720198C2779528694 @default.
- W2000720198 hasConceptScore W2000720198C2779609443 @default.
- W2000720198 hasConceptScore W2000720198C2780306776 @default.
- W2000720198 hasConceptScore W2000720198C2911091166 @default.
- W2000720198 hasConceptScore W2000720198C71924100 @default.
- W2000720198 hasConceptScore W2000720198C90924648 @default.
- W2000720198 hasIssue "11" @default.
- W2000720198 hasLocation W20007201981 @default.
- W2000720198 hasLocation W20007201982 @default.
- W2000720198 hasOpenAccess W2000720198 @default.
- W2000720198 hasPrimaryLocation W20007201981 @default.
- W2000720198 hasRelatedWork W1569816628 @default.
- W2000720198 hasRelatedWork W2010840551 @default.
- W2000720198 hasRelatedWork W2021983387 @default.
- W2000720198 hasRelatedWork W2052365623 @default.
- W2000720198 hasRelatedWork W2087086071 @default.
- W2000720198 hasRelatedWork W2091279747 @default.
- W2000720198 hasRelatedWork W2091491906 @default.
- W2000720198 hasRelatedWork W2294118878 @default.
- W2000720198 hasRelatedWork W2353739393 @default.
- W2000720198 hasRelatedWork W2589824098 @default.
- W2000720198 hasVolume "67" @default.
- W2000720198 isParatext "false" @default.
- W2000720198 isRetracted "false" @default.
- W2000720198 magId "2000720198" @default.
- W2000720198 workType "article" @default.